Login to Your Account



Other News To Note


Friday, August 31, 2012
• Pluristem Therapeutics Inc., of Haifa, Israel, said that it is requesting orphan drug status from the FDA for PLacental eXpanded (PLX) cells to treat aplastic anemia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription